EurekaMag.com logo
+ Translate

European biotechnology - scourge or saviour of the basic scientist?


, : European biotechnology - scourge or saviour of the basic scientist?. Trends in Biotechnology 12(7): 253-254

This article explores the dilemma facing governments and the scientific community on the role of science, particularly biotechnology, and how its public funding may be justified. It is argued that, despite efforts from the European Union, academic research in Europe is still being not successfully converted into industrial applications. Both the number of European biotechnology companies and patents issued are considerably smaller than those in the USA. Some important lessons that can be learnt from the USA experience are summarised. Changes are suggested to promote biotechnology transfer in Europe, including: the redefinition of the European Commission role on training and research project management, encouragement of PhD training at the academic-industry interface, professionalization of industrial liaison in academic institutions, maintenance of a smaller core of scientists engaged in fundamental research, increase in the number of publicly funded scientists engaged in applied science and more participation of industrial scientists in funding agencies.

Accession: 002373924

PMID: 7765072

DOI: 10.1016/0167-7799(94)90134-1

Download PDF Full Text: European biotechnology - scourge or saviour of the basic scientist?


Submit PDF Full Text

No spam - Every submission is manually reviewed

Due to poor quality, we do not accept files from Researchgate

Submitted PDF Full Texts will always be free for everyone
(We only charge for PDFs that we need to acquire)

Select a PDF file:
Close
Close

Related references

Holland, I.B., 1994: European biotechnology--scourge or saviour of the basic scientist?. Trends in Biotechnology 12(7): 253-254

Holland, I.Barry, 1994: European biotechnology-scourge or savior of the basic scientist?. Trends in Biotechnology 12(7): 253-254

Malavasi, F.; Cortese, R.; Albertini, A., 1992: European biotechnology today The impact of basic sciences on diagnosis and therapy First Conference on European Biotechnology Today. Malavasi, F , Cortese, R , Albertini, A European biotechnology today: The impact of basic sciences on diagnosis and therapy : XX+284P

Grodner, Ml, 2000: Biotechnology--savior or scourge?. Activities report of the R and D Associates3(1-2): 298-304

Anonymous, 2000: Safe biotechnology 10: DNA content of biotechnological process waste. The Safety in Biotechnology Working Party of the European Federation of Biotechnology. The adequacy of the existing treatment, disposal and recycling processes of waste streams from biotechnological laboratories and industrial processes, especially those using genetically modified microorganisms, have been repeatedly discussed. Here...

Lelieveld, H.L.; Boon, B.; Bennett, A.; Brunius, G.; Cantley, M.; Chmiel, A.; Collins, C.H.; Crooy, P.; Doblhoff-Dier, O.; Economidis, I.; Elmqvist, A.; Frontali-Botti, C.; Havenaar, R.; Haymerle, H.; Käppeli, O.; Leaver, G.; Lex, M.; Lund, S.; Mahler, J.L.; Marris, R.; Martinez, J.L.; Mosgaard, C.; Normand-Plessier, C.; Romantschuk, M.; Werner, R.G., 1996: Safe biotechnology. 7. Classification of microorganisms on the basis of hazard. Working Party "Safety in Biotechnology" of the European Federation Biotechnology. The current systems for classifying human pathogens on the basis of hazard are well developed and their basic criteria are in general agreement one with another. Of more importance, the safety practices based on these classifications have generall...

Lelieveld, H.L.; Bachmayer, H.; Boon, B.; Bennett, A.; Brunius, G.; Bürki, K.; Cantley, M.; Collard, J.M.; Collins, C.H.; Crooy, P.; Doblhoff-Dier, O.; Dubakiene, R.; Economidis, I.; Elmqvist, A.; Frontali-Botti, C.; Havenaar, R.; Haymerle, H.; Käppeli, O.; Leaver, G.; Lex, M.; Lund, S.; Mahler, J.L.; Marris, R.; Martinez, L.J.; Zhilevicha, A., 1997: Safe biotechnology. 8. Transport of infectious and biological materials. Working Party "Safety in Biotechnology" of the European Federation of Biotechnology. The transport of infectious and biological material is regulated by a number of international organizations. This mini-review has been compiled to increase awareness within the scientific community of problems caused by differences in terminology...

Doblhoff-Dier, O.; Bachmayer, H.; Bennett, A.; Brunius, G.; Bürki, K.; Cantley, M.; Collins, C.; Crooy, P.; Elmqvist, A.; Frontali-Botti, C.; Havenaar, R.; Haymerle, H.; Lelieveld, H.; Lex, M.; Mahler, J.L.; Martinez, L.; Mosgaard, C.; Olsen, L.; Pazlarova, J.; Rudan, F.; Sarvas, M.; Stepankova, H.; Tzotzos, G.; Wagner, K.; Werner, R., 1999: Safe biotechnology 9: values in risk assessment for the environmental application of microorganisms. The Safety in Biotechnology Working Party of the European Federation of Biotechnology. Risk assessment for the deliberate release of microorganisms into the environment is traditionally carried out on a case-by-case basis. In a similar approach to that used when assessing human pathogenicity, we propose an alternative approach by in...

Anonymous, 1964: Interface between basic medical sciences and their clinical branches Views of a basic scientist

Crespi R.S., 1988: Cambridge studies in biotechnology 6 patents a basic guide to patenting in biotechnology. This book presents a simplified exposition of basic patent law sufficient for the research scientist. The material is presented, primarily, in a question and answer format. Some aspects of the law are formally explained and examples and specific c...